Precision medicine, an emerging approach for disease treatment and prevention, holds immense potential in enhancing healthcare delivery. By considering individual variability in genes, environment, and lifestyle, precision medicine allows clinicians to predict more accurately which treatment and prevention strategies will work in specific patient groups.
Precision medicine is a paradigm shift from the traditional 'one-size-fits-all' approach. It involves the use of genomic information and other clinical data to stratify patients into different groups with similar medical characteristics. This stratification enables the development and application of targeted therapies, improving treatment efficacy and reducing adverse effects.
Genomics plays a crucial role in precision medicine. The sequencing of the human genome and advances in genomic technologies have facilitated the identification of genetic variants associated with diseases. This knowledge aids in the development of targeted therapies, risk prediction, and early disease detection.
Despite its potential, precision medicine faces challenges, including the integration of genomic data into electronic health records, interpretation of genomic data, and ethical issues related to genetic testing. Addressing these challenges requires a multidisciplinary approach involving clinicians, bioinformaticians, and ethicists. As genomic technologies continue to advance and become more affordable, the application of precision medicine is expected to expand, providing more personalized and effective healthcare.
Precision medicine represents a promising avenue for improving patient care. It offers the potential to tailor treatment to individual patients based on their genetic makeup and other unique characteristics. By embracing precision medicine, healthcare professionals can enhance treatment efficacy, improve patient outcomes, and transform the future of healthcare.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation